What you need to know about the FDA-approved drug for Alzheimer's

The drug in question is called Aducanumab, or Aduhelm. According to the latest study, the drug slows cognitive decline by 22%. Experts say this isn't enough, but the FDA and Alzheimer's Association believe it's worth a shot.